Streetbeat News

Price Targets

BMRN

Baird analyst Joel Beatty has maintained a Neutral rating on Biomarin Pharmaceutical (NASDAQ:BMRN) but has lowered the price target from $72 to $65.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:28 am

THRY

Needham analyst Scott Berg has reiterated a Buy rating on Thryv Holdings (NASDAQ:THRY) and maintained a price target of $28.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:28 am

MAS

Baird analyst Timothy Wojs maintains an Outperform rating on Masco (NYSE:MAS) but lowers the price target from $95 to $94.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:27 am

CROX

Baird analyst Jonathan Komp maintains an Outperform rating on Crocs (NASDAQ:CROX) but lowers the price target from $190 to $180.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:25 am

CMG

Baird analyst David Tarantino has maintained an Outperform rating on Chipotle Mexican Grill (NYSE:CMG) and raised the price target from $62 to $70.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:23 am

LEA

Barclays analyst Dan Levy has downgraded Lear Corporation (NYSE:LEA) from Overweight to Equal-Weight and reduced the price target from $140 to $120.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:22 am

CAKE

Baird analyst David Tarantino has maintained a Neutral rating on Cheesecake Factory (NASDAQ:CAKE) while raising the price target from $40 to $47.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:21 am

BOOT

Baird analyst Jonathan Komp has upgraded Boot Barn Holdings (NYSE:BOOT) from Neutral to Outperform, while maintaining the price target at $167.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:19 am

CAKE

Wedbush analyst Nick Setyan maintains an Outperform rating on Cheesecake Factory (NASDAQ:CAKE) and raises the price target from $48 to $52.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:16 am

INCY

B of A Securities has upgraded Incyte (NASDAQ:INCY) from Neutral to Buy, raising the price target from $68 to $90.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:14 am